高级检索
当前位置: 首页 > 详情页

Kindlin-2 induced by TGF-beta signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [2]Peking Univ, State Key Lab Nat & Biomimet Drugs, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [3]Dept Anat Histol & Embryol, Lab Mol Cell Biol & Tumor Biol, Beijing 100191, Peoples R China [4]Sinojapan Friendship Hosp, Dept Thorac Surg, Beijing 100123, Peoples R China [5]Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100191, Peoples R China
出处:
ISSN:

关键词: Kindlin-2 TGF-beta 1 HOXB9 Pancreatic cancer E-cadherin

摘要:
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths with no effective therapeutics. Invasion and metastasis are the major characteristics of PDAC. However, mechanisms underlying PDAC invasion and metastasis are elusive. In this report, we found that Kindlin-2 is a target protein of transforming growth factor beta (TGF-beta) signaling and is upregulated by TGF-beta 1 in PDAC cells. TGF-beta 1-upregulated Kindlin-2 promotes PDAC cell growth, migration and invasion, whereas Kindlin-2 upregulates transforming growth factor receptor I (T beta RI), a key component of TGF-beta signaling. Thereby Kindlin-2 and TGF-beta signaling constitute a positive feedback loop. Mechanistically, Kindlin-2 promotes PDAC progression by downregulation of HOXB9 and E-cadherin. For clinical relevance, enhanced expression of Kindlin-2 predicts a poor overall survival for PDAC patients. Gene expression levels of Kindlin-2, TGF-beta, VIZI and HOXB9 are all correlated with the overall survival of PDAC patients in an Oncomine dataset. Taken together, our findings demonstrated that TGF-beta 1-induced Kindlin-2 expression promotes PDAC progression by downregulation of HOXB9 and E-cadherin. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2013]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2013版] 出版当年五年平均[2009-2013] 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者单位: [1]Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [2]Peking Univ, State Key Lab Nat & Biomimet Drugs, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [3]Dept Anat Histol & Embryol, Lab Mol Cell Biol & Tumor Biol, Beijing 100191, Peoples R China
通讯作者:
通讯机构: [1]Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [2]Peking Univ, State Key Lab Nat & Biomimet Drugs, Minist Educ, Hlth Sci Ctr, Beijing 100191, Peoples R China [5]Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100191, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)